In RA, Tofacitinib Has Higher Infection Rate Than TNFi In RA, Tofacitinib Has Higher Infection Rate Than TNFi

Patients with rheumatoid arthritis are at greater risk for infection if they ' re treated with tofacitinib than with a tumor necrosis factor inhibitor (TNFi), according to an industry-funded study.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news